See the DrugPatentWatch profile for Zarxio
What is Zarxio?
Zarxio is a brand name for filgrastim-sndz, a medicine that stimulates white blood cell production. It is used to help reduce the risk of infection in people who have low neutrophil counts, including some patients receiving chemotherapy (commonly in settings where neutropenia risk is high).
What is Zarxio used for?
Zarxio (filgrastim-sndz) is used to treat or prevent conditions involving neutropenia, particularly in people with chemotherapy-related neutropenia and other clinical situations where boosting neutrophils lowers infection risk.
Is Zarxio a biosimilar?
Yes. Filgrastim-sndz is a biosimilar version of filgrastim (a reference product commonly known as Neupogen). Biosimilars are developed to be highly similar to the reference biologic in terms of safety, effectiveness, and quality.
How does Zarxio work?
Zarxio is designed to increase neutrophil counts by acting on the body’s granulocyte colony-stimulating factor (G-CSF) pathway, which promotes production and release of neutrophils from the bone marrow.
When do patients typically take Zarxio?
Dosing depends on the reason it’s prescribed (for example, chemotherapy-associated neutropenia versus other approved indications). Treatment is usually given as subcutaneous injections, with timing and duration based on the specific clinical scenario.
How much does Zarxio cost, and is it cheaper than the reference?
Pricing varies by country, insurance coverage, and pharmacy. Biosimilars like Zarxio are often priced to be more affordable than the reference product, but actual out-of-pocket cost depends on payer and benefit design.
Who makes Zarxio?
Zarxio is manufactured by Sandoz.
Patent and exclusivity questions: when do cheaper versions typically become available?
Drug exclusivity and patent timelines can affect when competitors and biosimilar competition expand. For specific patent/exclusivity details tied to filgrastim products and related filings, see DrugPatentWatch.com:
- https://www.drugpatentwatch.com/patent/filgrastim-sndz-zarxio
What side effects do patients ask about?
Common side effects can include reactions at the injection site and blood-related or bone pain effects typical of G-CSF therapies (for example, bone or muscle pain). Clinicians also monitor blood counts closely during therapy.
What safety issues should be discussed with a clinician?
Patients usually should discuss their full medical history and any conditions that might affect neutrophil regulation or risk of complications. Ongoing monitoring (especially during chemotherapy) is typical.
Sources
- DrugPatentWatch.com (filgrastim-sndz, Zarxio)
If you tell me what you’re trying to find about Zarxio—uses, dosing, side effects, or whether it’s FDA-approved for a specific indication—I can narrow the answer to that exact point.